Programs
Lysosomal Storage Disease Program
UF Lysosomal Storage Disease Program is committed to offering a comprehensive and personalized clinical care for patients suffering from lysosomal storage diseases (LSDs).
Projects
Identifying Small Molecule Therapies by HTS Assays Using LSD Patient Cells
We are developing robust high-throughput screening (HTS) cell-based assays using directly patient cell lines to screen selected libraries of drug-like compounds that enhance the residual activity of specific misfolded mutant enzymes.
Investigation of Pathogenic Cascades in LSDs as Potential Therapeutic Targets
we are currently establishing fibroblast-derived induced-neuronal (iN) cells from patients with LSDs. The iN cells from LSD will be crucial to investigate pathogenic cascades of neurological relevance. The aim is to investigate to confirm LMP in different LSDs and investigate the molecular mechanisms causing LMP and its downstream events in iN cells from LSD patients.
LSD Clinical Studies
Several clinical studies related to the natural history of different LSD and early and late phase clinical trials in collaboration different pharmaceuticals. Most subjects are evaluated and recruited for the studies in clinic.
UF Pediatric News
2020 Pediatric Progress Report
Tryp Therapeutics Plans Phase 2a Eating Disorder Clinical Trial with Dr. Jennifer Miller
The Florida Pediatrician, Winter 2021
Florida Providers See Increased Demand For Telehealth Visits
